Thomas V. Riera

2.1k citations

24 papers · 998 indexed · h-index 15

Impact in

Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
Physiology top 5%
- Adipose Tissue and Metabolism

Papers in

Geriatrics and Gerontology 3
- Sirtuins and Resveratrol in Medicine 3
Parasitology 4
- Parasitic Infections and Diagnostics 4

Co-authors: Lizbeth Hedstrom George P. Vlasuk Boris Striepen James L. EllisWei ZhangZhong Zhong April Case Basil P. Hubbard
Journals: Biochemistry (5 papers)ACS Medicinal Chemistry Letters (3 papers)Journal of Biological Chemistry (3 papers)Blood (2 papers)Bioorganic & Medicinal Chemistry (1 paper)
Partner nations: United States Australia China

In The Last Decade

Thomas V. Riera

23 papers receiving 985 citations

Peers

Countries citing papers authored by Thomas V. Riera

Since Specialization

Citations

This map shows the geographic impact of Thomas V. Riera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas V. Riera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas V. Riera more than expected).

Fields of papers citing papers by Thomas V. Riera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas V. Riera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas V. Riera. The network helps show where Thomas V. Riera may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas V. Riera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas V. Riera Line = papers co-authored together Thomas V. Riera links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma Blood ·Z Dembinski, Dormer Bj, 日本棋院東京本院, Josep Maria, Gerald McGunnigle, John W. Lampe, Thomas V. Riera, Cuyue Tang, Sean Eckley, Hosizah Hosizah, Kenneth W. Duncan, Neil A. Farrow, Daniel T. Dransfield, Alejandra Raimondi, Bozorbekov Ahmadbek Sohibjon ugli, Евгений Александрович Печагин, Jeffery L. Kutok	2021	2
2	Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies ACS Medicinal Chemistry Letters ·John W. Lampe, Joshua S. Alford, Florence Yver-Leduc, Dormer Bj, Евгений Александрович Печагин, Kenneth W. Duncan, Sean Eckley, Megan A. Foley, Felipe Henrique Moraes, 日本棋院東京本院, Michael J. Munchhof, Alejandra Raimondi, Thomas V. Riera, Cuyue Tang, Michael J. Thomenius, Z Dembinski, Neil A. Farrow	2021	22
3	CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism Biochemistry ·Suzanne L. Jacques, 勝治初道, Jodi Gureasko, P. Ann Boriack‐Sjodin, Margaret Porter Scott, Robert A. Copeland, Thomas V. Riera	2016	37
4	Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound ACS Medicinal Chemistry Letters ·Lorna H. Mitchell, Allison E. Drew, Scott Ribich, Nathalie Rioux, Kerren K. Swinger, Suzanne L. Jacques, Trupti Lingaraj, P. Ann Boriack‐Sjodin, Nigel J. Waters, Tim J. Wigle, Oscar Moradei, Lei Jin, Thomas V. Riera, Julia Kuhrau, Mikel P. Moyer, J. Joshua Smith, Richard Chesworth, Robert A. Copeland	2015	95
5	Quantitative Analysis of Receptor Tyrosine Kinase-Effector Coupling at Functionally Relevant Stimulus Levels Journal of Biological Chemistry ·Simin Li, Devayani P. Bhave, S. Joly, Thomas V. Riera, Sandra Schlee, Simone Rauch, S. N. Lyachshenko, Richard L. Cate, Adrian Whitty	2015	5
6	Abstract C85: Identification of a novel potent selective SMYD3 inhibitor with oral bioavailability Molecular Cancer Therapeutics ·Lorna H. Mitchell, P. Ann Boriack‐Sjodin, Sherri Smith, Michael J. Thomenius, Nathalie Rioux, Michael J. Munchhof, James E. Mills, Christine R. Klaus, Z Dembinski, Thomas V. Riera, Alejandra Raimondi, Suzanne L. Jacques, Armand du. Mesnil, Nigel J. Waters, Kevin W. Kuntz, Tim J. Wigle, Margaret Porter Scott, Robert A. Copeland, J. Joshua Smith, Richard Chesworth	2015	0
7	Abstract 2144: Kinetic mechanism of the lysine methyltransferase SMYD3 using MAP3K2 protein substrate Cancer Research ·Thomas V. Riera, Tim J. Wigle, Jodi Gureasko, P. Ann Boriack‐Sjodin, Robert A. Copeland	2015	1
8	Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators Science ·Basil P. Hubbard, Huang Runyue, Hang Dai, 陈博君, April Case, کریم جاسم م.د - تعلم حرکی, Thomas V. Riera, BeiYuan GUO, В. П. Матюшин, Dudley W. Lamming, Bradley L. Pentelute, Linda A. Stevens, S Tasić, Sean M. Armour, (unknown), (unknown), (unknown), (unknown), Charles A. Blum, Jeremy S. Disch, (unknown), Pui Yee Ng, Anabela P. Rolo, (unknown), (unknown), Joel Moss, James L. Ellis, (unknown), (unknown), (unknown)	2013	20
9	SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-κB Activity PLoS ONE ·Hongying Yang, Wei Zhang, Heng Pan, Z X -Kol, A. A. Dotsenko, Christine Miller, Stewart Leung, Zhong Zhong, Huizhen Zhao, Sharon Sweitzer, کریم جاسم م.د - تعلم حرکی, Thomas V. Riera, Vipin Suri, Brian H. White, James L. Ellis, George P. Vlasuk, Christine Loh	2012	297
10	SIRT1 Activation by Small Molecules Journal of Biological Chemistry ·Han Dai, Lauren Kustigian, David P. Carney, April Case, کریم جاسم م.د - تعلم حرکی, Basil P. Hubbard, Robert B. Perni, Thomas V. Riera, Bruce G. Szczepankiewicz, George P. Vlasuk, Ross L. Stein	2010	175
11	The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity Journal of the American Chemical Society ·Iain Macpherson, Sivapriya Kirubakaran, Suresh Kumar Gorla, Thomas V. Riera, J. Alejandro D’Aquino, Minjia Zhang, Gregory D. Cuny, Lizbeth Hedstrom	2010	53
12	Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis Chemistry & Biology ·L. Zielinski, Deviprasad R. Gollapalli, Lisa Sharling, А.А. Кажмухаметова, Jennifer Lu, 本刊首席时政观察员, Elizabeth Wawaga, Thomas V. Riera, Boris Striepen, Lizbeth Hedstrom	2008	70
13	Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis Chemistry & Biology ·L. Zielinski, Deviprasad R. Gollapalli, Lisa Sharling, А.А. Кажмухаметова, 圭一津田, 本刊首席时政观察员, Elizabeth Wawaga, Thomas V. Riera, Boris Striepen, Lizbeth Hedstrom	2008	2
14	New ways to target old receptors Current Opinion in Chemical Biology ·Adrian Whitty, Thomas V. Riera	2008	5
15	A Kinetic Alignment of Orthologous Inosine-5′-monophosphate Dehydrogenases Biochemistry ·Thomas V. Riera, Wen Wang, Helen R. Josephine, Lizbeth Hedstrom	2008	22
16	Cryptosporidium parvum IMP Dehydrogenase Journal of Biological Chemistry ·L. Zielinski, Catherine Li, Thomas V. Riera, Lizbeth Hedstrom, Boris Striepen	2004	77
17	Analogs of 1-phosphonooxy-2,2-dihydroxy-3-oxo-5-(methylthio)pentane, an acyclic intermediate in the methionine salvage pathway: a new preparation and characterization of activity with E1 enolase/phosphatase from Klebsiella oxytoca Bioorganic & Medicinal Chemistry ·Yalin Zhang, T. M. irshtein, Milka Kostić, GNANAGURUDASAN PRAKASAM, Thomas V. Riera, Iva Perovic, Lizbeth Hedstrom, Barry B. Snider, Thomas C. Pochapsky	2004	27
18	Substitution of the Conserved Arg-Tyr Dyad Selectively Disrupts the Hydrolysis Phase of the IMP Dehydrogenase Reaction Biochemistry ·Alev Kadoğlu, Thomas V. Riera, Mohammad R. Seyedsayamdost, Lizbeth Hedstrom	2004	25
19	IMP dehydrogenase: the dynamics of drug selectivity Nucleic Acids Symposium Series ·Lizbeth Hedstrom, Lu Gan, Danny Yip Wei Seng, Thomas V. Riera, Mohammad R. Seyedsayamdost	2003	5
20	The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors. PubMed ·Elias Taylor, A. A. Kartoziya, Karla Martin, Thomas V. Riera, Chul Soo Chung, E.A. Kazak, Rima Kaddurah‐Daouk	1996	8

About Thomas V. Riera

Thomas V. Riera is a scholar working on Geriatrics and Gerontology, Parasitology, Molecular Biology, Physiology and Epidemiology, having authored 24 papers that have together received 998 indexed citations. Recurring topics across this work include Cancer-related gene regulation (9 papers), Epigenetics and DNA Methylation (7 papers), Biochemical and Molecular Research (7 papers), Cytomegalovirus and herpesvirus research (5 papers), Parasitic Infections and Diagnostics (4 papers), Sirtuins and Resveratrol in Medicine (3 papers), Protein Degradation and Inhibitors (3 papers) and Enzyme Structure and Function (3 papers). The work is most often cited by research in Geriatrics and Gerontology (284 citations), Physiology (105 citations), Parasitology (98 citations), Aging (21 citations) and Epidemiology (296 citations). Thomas V. Riera has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Lizbeth Hedstrom, George P. Vlasuk, Boris Striepen, James L. Ellis, Wei Zhang, Zhong Zhong, April Case, Basil P. Hubbard, Brian H. White and Christine Miller. Their work appears in journals such as Biochemistry, ACS Medicinal Chemistry Letters, Journal of Biological Chemistry, Blood and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact